Hesperetin effect on MLH1 and MSH2 expression on breast cancer cells BT-549

Due to its genetic and phenotypic heterogeneity, breast cancer is very difficult to eliminate. The harmful consequences of conventional therapies like radiation and chemotherapy have prompted the search for organic-based alternatives. Hesperetin (HSP), a flavonoid, has been discovered to possess the...

Full description

Bibliographic Details
Main Authors: Assim Khattab Hasan, Esmaeil Babaei, Ahmed Salim Kadhim Al-Khafaji
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Journal of Advanced Pharmaceutical Technology & Research
Subjects:
Online Access:http://www.japtr.org/article.asp?issn=2231-4040;year=2023;volume=14;issue=3;spage=241;epage=247;aulast=Hasan
_version_ 1797738644587413504
author Assim Khattab Hasan
Esmaeil Babaei
Ahmed Salim Kadhim Al-Khafaji
author_facet Assim Khattab Hasan
Esmaeil Babaei
Ahmed Salim Kadhim Al-Khafaji
author_sort Assim Khattab Hasan
collection DOAJ
description Due to its genetic and phenotypic heterogeneity, breast cancer is very difficult to eliminate. The harmful consequences of conventional therapies like radiation and chemotherapy have prompted the search for organic-based alternatives. Hesperetin (HSP), a flavonoid, has been discovered to possess the ability to hinder the proliferation of cell associated with breast cancer by acting as an epigenetic agent and modifying gene expression. In this investigation, breast cancer cells (BT-549) and normal cells (MCF-10a) were subjected to the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) test and three different doses (200, 400, and 600 μM/mL) of HSP for real-time polymerase chain reaction and flow cytometry to examine its cytotoxic and anti-malignant potential. HSP was shown to be cytotoxic to both normal and breast cancer cells, but had a more pronounced effect on the cancer cell lines. After 48 h of treatment, the half-maximal inhibitory concentration (IC50) for BT-549 was 279.2 μM/mL, whereas the IC50 for MCF-10a was 855.4 μM/mL. At high HSP concentrations, upregulation of the MLH1 and MSH2 genes was observed in both cell lines. The influence of HSP on MLH1 gene expression was concentration dependent. Moreover, HSP had a concentration-dependent effect on MSH2 gene expression in the BT-549 cell line but not in the MCF-10a cell line. Cell death and early apoptosis were shown to be concentration dependent upon the application of HSP, as determined by flow cytometric analysis. HSP's capacity to cause apoptosis and its stronger impact on the malignant cell line when analyzed with the normal cell line imply that it might be useful as an effective therapeutic approach for combating breast cancer.
first_indexed 2024-03-12T13:45:50Z
format Article
id doaj.art-299f206fa38d443ab4090ef7158d3896
institution Directory Open Access Journal
issn 2231-4040
0976-2094
language English
last_indexed 2024-03-12T13:45:50Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Advanced Pharmaceutical Technology & Research
spelling doaj.art-299f206fa38d443ab4090ef7158d38962023-08-23T08:57:25ZengWolters Kluwer Medknow PublicationsJournal of Advanced Pharmaceutical Technology & Research2231-40400976-20942023-01-0114324124710.4103/japtr.japtr_277_23Hesperetin effect on MLH1 and MSH2 expression on breast cancer cells BT-549Assim Khattab HasanEsmaeil BabaeiAhmed Salim Kadhim Al-KhafajiDue to its genetic and phenotypic heterogeneity, breast cancer is very difficult to eliminate. The harmful consequences of conventional therapies like radiation and chemotherapy have prompted the search for organic-based alternatives. Hesperetin (HSP), a flavonoid, has been discovered to possess the ability to hinder the proliferation of cell associated with breast cancer by acting as an epigenetic agent and modifying gene expression. In this investigation, breast cancer cells (BT-549) and normal cells (MCF-10a) were subjected to the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) test and three different doses (200, 400, and 600 μM/mL) of HSP for real-time polymerase chain reaction and flow cytometry to examine its cytotoxic and anti-malignant potential. HSP was shown to be cytotoxic to both normal and breast cancer cells, but had a more pronounced effect on the cancer cell lines. After 48 h of treatment, the half-maximal inhibitory concentration (IC50) for BT-549 was 279.2 μM/mL, whereas the IC50 for MCF-10a was 855.4 μM/mL. At high HSP concentrations, upregulation of the MLH1 and MSH2 genes was observed in both cell lines. The influence of HSP on MLH1 gene expression was concentration dependent. Moreover, HSP had a concentration-dependent effect on MSH2 gene expression in the BT-549 cell line but not in the MCF-10a cell line. Cell death and early apoptosis were shown to be concentration dependent upon the application of HSP, as determined by flow cytometric analysis. HSP's capacity to cause apoptosis and its stronger impact on the malignant cell line when analyzed with the normal cell line imply that it might be useful as an effective therapeutic approach for combating breast cancer.http://www.japtr.org/article.asp?issn=2231-4040;year=2023;volume=14;issue=3;spage=241;epage=247;aulast=Hasanapoptosisbreast cancerbt 549 cellsflow cytometryhesperetinmic50mlh1mrna expressionmsh2mtt assay
spellingShingle Assim Khattab Hasan
Esmaeil Babaei
Ahmed Salim Kadhim Al-Khafaji
Hesperetin effect on MLH1 and MSH2 expression on breast cancer cells BT-549
Journal of Advanced Pharmaceutical Technology & Research
apoptosis
breast cancer
bt 549 cells
flow cytometry
hesperetin
mic50
mlh1
mrna expression
msh2
mtt assay
title Hesperetin effect on MLH1 and MSH2 expression on breast cancer cells BT-549
title_full Hesperetin effect on MLH1 and MSH2 expression on breast cancer cells BT-549
title_fullStr Hesperetin effect on MLH1 and MSH2 expression on breast cancer cells BT-549
title_full_unstemmed Hesperetin effect on MLH1 and MSH2 expression on breast cancer cells BT-549
title_short Hesperetin effect on MLH1 and MSH2 expression on breast cancer cells BT-549
title_sort hesperetin effect on mlh1 and msh2 expression on breast cancer cells bt 549
topic apoptosis
breast cancer
bt 549 cells
flow cytometry
hesperetin
mic50
mlh1
mrna expression
msh2
mtt assay
url http://www.japtr.org/article.asp?issn=2231-4040;year=2023;volume=14;issue=3;spage=241;epage=247;aulast=Hasan
work_keys_str_mv AT assimkhattabhasan hesperetineffectonmlh1andmsh2expressiononbreastcancercellsbt549
AT esmaeilbabaei hesperetineffectonmlh1andmsh2expressiononbreastcancercellsbt549
AT ahmedsalimkadhimalkhafaji hesperetineffectonmlh1andmsh2expressiononbreastcancercellsbt549